Lv42
706 积分 2020-11-02 加入
Rezvilutamide: First Approval
14天前
已完结
Sevabertinib: First Approval
28天前
已完结
Comparative effectiveness of mineralocorticoid receptor antagonists in cardiovascular, renal and metabolic disease
1个月前
已关闭
Comparative Effectiveness of Mineralocorticoid Receptor Antagonists in Cardiovascular, Renal and Metabolic Disease
1个月前
已关闭
Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR
1个月前
已完结
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure
1个月前
已关闭
Finerenone in Type 1 Diabetes and Chronic Kidney Disease
1个月前
已完结
Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis
1个月前
已关闭
Clinical Approach to Heart Failure with Preserved Ejection Fraction(HFpEF) in South Asia: An Expert Consensus Statement
1个月前
已完结
达罗他胺联合雄激素剥夺治疗对转移性激素敏感性前列腺癌患者PSA水平的影响
2个月前
已完结
皖公网安备34019202002308
